Echinocandin-based initial therapy in fungemic patients with cancer: A focus on recent guidelines of the infectious diseases society of america

Clinical Infectious Diseases

Volumn 49, Issue 4, 2009, Pages 638-639

  Kontoyiannis, Dimitrios P ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; ECHINOCANDIN; FLUCONAZOLE; VORICONAZOLE;

CANCER PATIENT; FUNGEMIA; HUMAN; LETTER; MEDICAL SOCIETY; PRACTICE GUIDELINE; PRIORITY JOURNAL;

ADULT; ANTIFUNGAL AGENTS; ECHINOCANDINS; FUNGEMIA; GUIDELINES AS TOPIC; HUMANS; NEOPLASMS;

EID: 67651095582     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/603585     Document Type: Letter

References (10)

1. Pappas PG, Kauffman CA, Andes D, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 48:503-25.
2. Walsh TJ, Teppler H, Donowitz GR, et al. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med 2004; 351:1391-402.
3. Panackal AA, Gribskov JL, Staab JF, Kirby KA, Rinaldi M, Marr KA. Clinical significance of azole antifungal cross-resistance in Candida glabrata. J Clin Micro biol 2006; 44:1740-3.
4. DiNubile MJ, Hille D, Sable CA, Kartsonis NA. Invasive candidiasis in cancer patients: observations from a randomized clinical trial. J Infect 2005; 50:443-9.
5. Sipsas NV, Lewis RE, Raad II, Kontoyiannis DP. Monotherapy with caspofungin for can- didemia in adult patients with cancer: a retrospective single institution study. Int J Antimicrob Agents 2009; 34:95-8.
6. Sipsas NV, Lewis RE, Tarrand J, et al. Can- didemia in patients with hematologic malignancies in the era of new antifungal agents (2000-2007): stable incidence but changing epidemiology of a still frequently lethal infection. Cancer (in press).
7. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39:309-17.
8. Garcia-Effron G, Kontoyiannis DP, Lewis RE, Perlin DS. Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignancies. Antimicrob Agents Chemother 2008; 52:4181-3.
9. Denning DW. Echinocandin antifungal drugs. Lancet 2003;362:1142- 51.
10. Pfaller MA, Diekema DJ, Ostrosky-Zeichner L, et al. Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints. J Clin Microbiol 2008; 46:2620-9.